Cargando…
Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas
Background: Dopamine agonists (DA) are the first line therapy for prolactinoma and symptomatic hyperprolactinemia; use as an adjuvant treatment for acromegaly and Cushing's disease is rare. Some patients develop de novo psychiatric symptoms or have exacerbation of pre-existing conditions during...
Autores principales: | Hinojosa-Amaya, José Miguel, Johnson, Nathaniel, González-Torres, Christina, Varlamov, Elena V., Yedinak, Christine G., McCartney, Shirley, Fleseriu, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652723/ https://www.ncbi.nlm.nih.gov/pubmed/33193096 http://dx.doi.org/10.3389/fendo.2020.579606 |
Ejemplares similares
-
MON-277 Patient Health Questionnaire 9 (PHQ-9) and Barrat Impulsivity Scale (BIS-11); Tools to Identify Side Effects of Dopamine Agonist Treatment in Patients with Pituitary Adenomas
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2020) -
Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge
por: Hinojosa-Amaya, José Miguel, et al.
Publicado: (2019) -
Functioning Pituitary Adenomas – Current Treatment Options and Emerging Medical Therapies
por: Varlamov, Elena V, et al.
Publicado: (2019) -
Dopamine Agonists for Pituitary Adenomas
por: Cooper, Odelia, et al.
Publicado: (2018) -
Recent Progress in the Medical Therapy of Pituitary Tumors
por: Langlois, Fabienne, et al.
Publicado: (2017)